Correlation of Hypoglycemia and Cognitive Impairment in Older Patients with Type 2 Diabetes Mellitus
https://doi.org/10.37586/2686-8636-2-2024-108-116
Abstract
Type 2 diabetes mellitus (T2DM) is one of the most common chronic non-communicable diseases, and the rate of increase is higher than predicted. This is an age-associated disease that is more common among older patients, whose proportion is also increasing in both absolute and relative age groups. Despite advances in the treatment of T2DM and a wide range of hypoglycemic drugs, complications of this disease, primarily micro- and macrovascular, remain a public health problem. It is also known that T2DM is a risk factor for the development of dementia. Furthermore, there remains a significant prevalence of hypoglycemia among patients with T2DM who are undergoing hypoglycemic therapy. This poses a potential threat to older patients, increasing their risk for cardiovascular events and exacerbating cognitive impairments, because glucose is the primary energy substrate for the nervous system. Understanding the impact of hypoglycemia on the development of dementia in older patients and how these events interact, as discussed in this review, can further assist in developing prevention and risk minimization strategies.
About the Authors
S. V. BulgakovaRussian Federation
Bulgakova Svetlana V., MD, PhD, professor, Head of the Department of Endocrinology and Geriatrics
Samara
P. Ya. Merzlova
Russian Federation
Merzlova Polina Y., MD, Assistant Professor, Department of Endocrinology and Geriatrics
Samara
D. P. Kurmaev
Russian Federation
Kurmaev Dmitry P., MD, PhD, Assistant Professor, Endocrinology and Geriatrics Department
Samara
E. V. Treneva
Russian Federation
Treneva Ekaterina V., MD, PhD, Associate Professor, Department of Endocrinology and Geriatrics
Samara
References
1. United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population Prospects 2019: Highlights (ST/ESA/SER.A/423). https://population.un.org/wpp/publications/files/wpp2019_highlights.pdf
2. Lazebnik L.B., Konev Yu.V., Efremov L.I. The main problem of geriatrics: the multiplicity of diseases in elderly patients. Clinical gerontology. 2019;(1-2):4-9. (In Russ.)] https://doi.org/10.26347/1607-2499201901-02004-009
3. Dedov I.I., Shestakova M.V., Mayorov A.U., et al. Diabetes Mellitus 2 type in adults. Clinical guidelines Russian Association of Endocrinologists. 2022. (In Russ.)] https://rae-org.ru/system/files/documents/pdf/cr_dm_ii_ad_2022.pdf
4. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium; 2021. https://diabetesatlas.org/atlas/tenth-edition/
5. Dedov I.I., Shestakova M.V., Vikulova O.K., et al. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Diabetes mellitus. 2023;26(2):104-123. (In Russ.)] https://doi.org/10.14341/DM13035
6. Dedov I.I., Shestakova M.V., Vikulova O.K., et al. Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017. Diabetes mellitus. 2018;21(3):144-159. (In Russ.)] https://doi.org/10.14341/DM9686
7. Dedov I.I., Shestakova M.V., Mayorov A.Y., et al. Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Y. 8th edition. Diabetes mellitus. 2017;20(1S):1-121. (In Russ.)] https://doi.org/10.14341/DM20171S8
8. Dedov I.I., Shestakova M.V., Mayorov A.Y., et al. Algorithms of Specialized Medical Care for Diabetes Mellitus Patients. Edited by Dedov I.I., Shestakova M.V. (11th edition). Diabetes mellitus. 2023;73-74. (in Russ.)] https://rae-org.ru/system/files/documents/pdf/2023_alg_sum.pdf
9. Belyaeva N.G. Hypoglycemia: prevalence and risk factors in hospitalized patients with type 2 diabetes mellitus. RMJ. 2020;1:4042. (In Russ.)] https://www.rmj.ru/articles/endokrinologiya/Gipoglikemiya_rasprostranennosty_i_faktory_riska_u_pacientov_s_saharnym_diabetom_2_tipa_v_usloviyah_stacionarnogo_lecheniya/
10. Akhundova K.R., Dudinskaya E.N., Tkacheva O.N. Geriatric aspects of diabetes mellitus. Russian Journal of Geriatric Medicine. 2020;(3):250-259. (In Russ.)] https://doi.org/10.37586/2686-8636-3-2020-250-259
11. Yun JS, Ko SH. Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus. Diabetes Metab J. 2016;40(6):423-432. https://doi.org/10.4093/dmj.2016.40.6.423
12. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-2559. https://doi.org/10.1056/NEJMoa0802743
13. ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-2572. https://doi.org/10.1056/NEJMoa0802987
14. Edridge CL, Dunkley AJ, Bodicoat DH, et al. Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies. PLoS One. 2015;10(6):e0126427. https://doi.org/10.1371/journal.pone.0126427
15. Misnikova IV, Kovaleva YA, Isakov MA, Dreval AV. The glucose-lowering therapy structure in special groups of type 2 diabetes mellitus patients based on data from the Moscow Region Register. Diabetes Mellitus. 2019;22(3):206-216. (In Russ.)] https://doi.org/10.14341/DM10084
16. Yakhno N.N., Tkacheva O.N., Gavrilova S.I., et al. Comprehensive interdisciplinary and interdepartmental program for prevention, early detection, diagnosis and treatment of cognitive disorders in older and senile people. Russian Journal of Geriatric Medicine. 2022;(1):6-16. (In Russ.)] https://doi.org/10.37586/2686-8636-1-2022-6-16
17. Ostroumova O.D., Surkova E.V., Chikh E.V., et al. Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs. Diabetes mellitus. 2018;21(4):307-318. (In Russ.)] https://doi.org/10.14341/DM9660
18. Lopez OL, Kuller LH. Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer's disease and other dementias. Handb Clin Neurol. 2019;167:139-148. https://doi.org/10.1016/B978-0-12-804766-8.00009-1
19. Mkhitaryan E.A., Vorobieva N.M., Tkacheva O.N., et al. The prevalence of cognitive impairment and their association with socioeconomic, demographic and anthropometric factors and geriatric syndromes in people over 65 years of age: data from the Russian epidemiological study EVKALIPT. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2022;14(3):44–53. (In Russ.)] https://doi.org/10.14412/2074-2711-2022-3-44-53
20. Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4(6):640-650. https://doi.org/10.1111/jdi.12087
21. Husain KH, Sarhan SF, AlKhalifa HKAA, et al. Dementia in Diabetes: The Role of Hypoglycemia. Int J Mol Sci. 2023;24(12):9846. https://doi.org/10.3390/ijms24129846
22. Yaffe K, Falvey CM, Hamilton N, et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med. 2013;173(14):1300-1306. https://doi.org/10.1001/jamainternmed.2013.6176
23. Morgan RK, Cortes Y, Murphy L. Pathophysiology and aetiology of hypoglycaemic crises. J Small Anim Pract. 2018;59(11):659-669. https://doi.org/10.1111/jsap.12911
24. Rehni AK, Dave KR. Impact of Hypoglycemia on Brain Metabolism During Diabetes. Mol Neurobiol. 2018;55(12):90759088. https://doi.org/10.1007/s12035-018-1044-6
25. Antonova K.V., Lagoda O.V., Tanashyan M.M. Hypoglycemia in type 2 diabetes mellitus patients — cerebral, cognitive, psychosocial and clinical aspects. Diabetes mellitus. 2022;25(3):288298. (In Russ.)] https://doi.org/10.14341/DM12840
26. Nistor M, Schmidt M, Graul I, et al. A Systematic Review of Neuroprotective Strategies in the Management of Hypoglycemia. Int J Mol Sci. 2019;20(3):550. https://doi.org/10.3390/ijms20030550
27. Heller SR, Peyrot M, Oates SK, Taylor AD. Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen. BMJ Open Diabetes Res Care. 2020;8(1):e001194. https://doi.org/10.1136/bmjdrc-2020-001194
28. Alkhatatbeh MJ, Abdalqader NA, Alqudah MAY. Impaired Awareness of Hypoglycaemia in Insulin-treated Type 2 Diabetes Mellitus. Curr Diabetes Rev. 2019;15(5):407-413. https://doi.org/10.2174/157339981466618080614493
29. Huang L, Zhu M, Ji J. Association between hypoglycemia and dementia in patients with diabetes: a systematic review and meta-analysis of 1.4 million patients. Diabetol Metab Syndr. 2022;14(1):31. https://doi.org/10.1186/s13098-022-00799-9
30. Mattishent K, Loke YK. Meta-Analysis: Association Between Hypoglycemia and Serious Adverse Events in Older Patients Treated With Glucose-Lowering Agents. Front Endocrinol (Lausanne). 2021;12:571568. https://doi.org/10.3389/fendo.2021.571568
31. Mehta HB, Mehta V, Goodwin JS. Association of Hypoglycemia With Subsequent Dementia in Older Patients With Type 2 Diabetes Mellitus [published correction appears in J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):750]. J Gerontol A Biol Sci Med Sci. 2017;72(8):1110-1116. https://doi.org/10.1093/gerona/glw217
32. Gómez-Guijarro MD, Álvarez-Bueno C, Saz-Lara A, et al. Association between severe hypoglycaemia and risk of dementia in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2023;39(3):e3610. https://doi.org/10.1002/dmrr.3610
33. Dong S, Wang L, Zhao C, et al. Relationship between key continuous glucose monitoring-derived metrics and specific cognitive domains in patients with type 2 diabetes mellitus. BMC Neurol. 2023;23(1):200. https://doi.org/10.1186/s12883-023-03242-2
34. McMillan JM, Mele BS, Hogan DB, Leung AA. Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2018;6(1):e000563. https://doi.org/10.1136/bmjdrc-2018-000563
35. Song J, Bai H, Xu H, et al. HbA1c Variability and the Risk of Dementia in Patients with Diabetes: A MetaAnalysis. Int J Clin Pract. 2022;2022:7706330. https://doi.org/10.1155/2022/7706330
36. Ardanaz CG, Ramírez MJ, Solas M. Brain Metabolic Alterations in Alzheimer's Disease. Int J Mol Sci. 2022;23(7):3785. https://doi.org/10.3390/ijms23073785
37. Lauretti E, Li JG, Di Meco A, Praticò D. Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model. Transl Psychiatry. 2017;7(1):e1020. https://doi.org/10.1038/tp.2016.296
38. Saik OV, Klimontov VV. Hypoglycemia, Vascular Disease and Cognitive Dysfunction in Diabetes: Insights from Text Mining-Based Reconstruction and Bioinformatics Analysis of the Gene Networks. Int J Mol Sci. 2021;22(22):12419. https://doi.org/10.3390/ijms222212419
39. Kim YG, Park DG, Moon SY, et al. Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study. Diabetes Metab J. 2020;44(1):125-133. https://doi.org/10.4093/dmj.2018.0260
40. Klingbeil KD, Koch S, Dave KR. Potential link between postacute ischemic stroke exposure to hypoglycemia and hemorrhagic transformation. Int J Stroke. 2020;15(5):477-483. https://doi.org/10.1177/1747493017743797
41. Smith L, Chakraborty D, Bhattacharya P, et al. Exposure to hypoglycemia and risk of stroke. Ann N Y Acad Sci. 2018;1431(1):25-34. https://doi.org/10.1111/nyas.13872
42. Kaplan ZS, Jackson SP. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program. 2011;2011:51-61. https://doi.org/10.1182/asheducation-2011.1.51
43. Chow E, Iqbal A, Walkinshaw E, et al. Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes. Diabetes Care. 2018;41(12):2625-2633. https://doi.org/10.2337/dc18-0050
44. Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363(15):14101418. https://doi.org/10.1056/NEJMoa1003795
45. Lee AK, Warren B, Lee CJ, et al. The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes. Diabetes Care. 2018;41(1):104-111. https://doi.org/10.2337/dc17-1669
46. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [published correction appears in Stroke. 2019 Dec;50(12):e440-e441]. Stroke. 2019;50(12):e344-e418. https://doi.org/10.1161/STR.0000000000000211
47. Alsharif AA, Wong ICK, Ma T, et al. The association between dementia and the risk of hypoglycaemia events among patients with diabetes mellitus: a propensity-score matched cohort analysis. Front Med (Lausanne). 2023;10:1177636. https://doi.org/10.3389/fmed.2023.1177636
48. Settles J, Kan H, Child CJ, et al. Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin-treated type 2 diabetes: Results from a real-world nested case-control study. Diabetes Obes Metab. 2022;24(7):1235-1244. https://doi.org/10.1111/dom.14690
49. de Galan BE, Zoungas S, Chalmers J, et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2009;52(11):23282336. https://doi.org/10.1007/s00125-009-1484-7
50. Punthakee Z, Miller ME, Launer LJ, et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care. 2012;35(4):787-793. https://doi.org/10.2337/dc11-1855
51. Mattishent K, Loke YK. Bi-directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose-lowering agents: a systematic review and metaanalysis. Diabetes Obes Metab. 2016;18(2):135-141. https://doi.org/10.1111/dom.12587
Review
For citations:
Bulgakova S.V., Merzlova P.Ya., Kurmaev D.P., Treneva E.V. Correlation of Hypoglycemia and Cognitive Impairment in Older Patients with Type 2 Diabetes Mellitus. Russian Journal of Geriatric Medicine. 2024;(2):108-116. (In Russ.) https://doi.org/10.37586/2686-8636-2-2024-108-116